Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SurfSubQ - A Prospective Longitudinal Multicenter Observational Study to Investigate Neurofilament Light Chain Levels and Patient Satisfaction After Subcutaneous Ocrelizumab Administration in Persons With Multiple Sclerosis

NCT06780150 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT06780150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06780150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SurfSubQ - A Prospective Longitudinal Multicenter Observational Study to Investigate Neurofilament Light Chain Levels and Patient Satisfaction After Subcutaneous Ocrelizumab Administration in Persons With Multiple Sclerosis
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Recruiting
Start date
September 26, 2024
Completion date
March 31, 2028
Enrollment
842 (estimated)
Sites
93

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis